2023Journal articleFree to read
Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee
Frontiers in Oncology
Women in Gastrointestinal Cancer Vol II: 2022 EDITORIAL This editorial presents the inaugural Frontiers in Oncology (FIO) 'Women in Gastrointestinal Cancer Vol II: 2022" series of article collections. The research topic collection highlights the diversity of research performed across the entire breadth of oncology research by women scientists pursuing STEM careers. Nine (9) research articles, from 14 submitted to FIO within this section, published under this research topic by 92 authors, aimed to present advances in theory, experiment, and methodology, with applications to compelling problems related to gastric cancers: gastrointestinal (GI) cancer: Hepato-Pancreatic Biliary (HPB) cancers. 1/9 is a brief research report article titled "the BET inhibitor JQ1 potentiates the anticlonogenic effect of radiation in pancreatic cancer cells". 1/9 is a case report article titled "a female with synchronous multiple primary malignant tumors in the esophagogastric junction, duodenum, and pancreas: Case report and review of the literature". Methodology Clinical trial article 1/9 under the title "implementing pharmacogenetic testing in gastrointestinal cancers (IMPACT-GI): Study Protocol for a Pragmatic Implementation Trial for Establishing DPYD and UGT1A1 screening to guide chemotherapy dosing". Four out of the nine (4/9) published articles are original research articles exploring the tumor-immune interactions in the tumor microenvironment (TME) and identifying new prognostic and/or therapeutic biomarkers to assist in novel decoding mechanism(s) of tumor immunotherapy as well as being confined with personalized treatment based on geno/pheno-typic evaluations. These four articles are, first "Evaluation of Galanin Expression in Colorectal Cancer (CRC): An Immunohistochemical (IHC)…
Abstract shortened. Read the full abstract at the source.
Abstract text comes from PubMed, OpenAlex or Europe PMC and belongs to the authors and publisher.
Study type
Systematic review / meta-analysis
A structured search and combined analysis of earlier studies.
Assigned automatically from the title, abstract and subject terms.
Topics
Matcha is a main subject here (named in the keywords).
Nadia Μ. Hamdy, Lisardo Boscá, Sukh Mahendra Singh, Srinivasa Reddy Bonam, Igor Kišš, Divya P. Kumar, Aditi Banerjee. (2023). Editorial: Women in gastrointestinal cancers, volume II: 2022. Frontiers in Oncology. https://doi.org/10.3389/fonc.2023.1192814
DOI: 10.3389/fonc.2023.1192814 · PubMed ID: 37265801
Monitoring chlorophyll during Tencha (the raw ingredient for matcha) processing is critical for determining the matcha's color and quality. The purpose of this study is to explore the mechanism of chlorophyll changes during Tencha…
Chemical / analyticalCultivation and shadingProcessing, milling and qualityAuthenticity and analytical methodsCited 91×The importance of postprandial hyperglycemia in the treatment of diabetes has been recognized recently. Tea products, such as tea polyphenols (TP), epigallocatechin gallate (EGCG), matcha, and instant tea, were chosen as constituents of…
In vitro / cell studyMetabolism and weightAntioxidants and polyphenolsGut and microbiomeCited 76×Objective: Gut microbiota plays a key role in metabolism and health in diabetes patients with gastrointestinal microbiota dysbiosis. Thus, regulating the ecological balance of gut microbiota may provide a pathway toward improvement for…
Animal studyMetabolism and weightGut and microbiomeMarket, culture and sustainabilityCited 68×Matcha green tea (MGT) is a natural product that is currently used as a dietary supplement and may have significant anti-cancer properties. However, the molecular mechanism(s) underpinning its potential health benefits remain largely…
In vitro / cell studyMetabolism and weightAntioxidants and polyphenolsCancerCited 66×